![]() ![]() Bivalent vaccines are to be used for all doses given to individuals 6 months of age and older. ![]() Arexvy (GSK) is approved for individuals 60 years of age and older.įDA authorizes additional dose(s) of Pfizer-BioNTech COVID-19 Vaccine, Bivalent for 6 months through 4 years of age with immunocompromise who have previously received three 0.2 mL doses (Pfizer-BioNTech COVID-19 Vaccine or Pfizer-BioNTech COVID-19 Vaccine, Bivalent)įDA approves Prevnar 20 (Pfizer) for infants and children, now approved for individuals 6 weeks and olderĬDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the bivalent vaccine.įDA amends EUAs of Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. You know of an event that you would like us to add, contact us at and related notesįDA approves Abrysvo (Pfizer) respiratory syncytial virus (RSV) vaccine, approved for individuals 60 years of age and older.įDA approves the first respiratory syncytial virus (RSV) vaccine. Immunization-related events that have occurred since Jenner's criticalĭiscovery. The chart which follows displays many of the vaccine- and ![]() Slow rate until the last several decades when new scientific discoveries and technologies led to rapid advances in virology, molecular biology, and vaccinology. The development of vaccines continued at a fairly Historic Dates and Events Related to Vaccines and ImmunizationĬelebrated the 200th anniversary of Edward Jenner's first smallpox ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |